Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor.

Routh JC, Grundy PE, Anderson JR, Retik AB, Kurek KC. B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor. J Urol. 2013 Apr; 189(4):1487-92.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.